Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations

Mikael Lantz,Jan Calissendorff,Frank Träisk,Leif Tallstedt,Tereza Planck,Ove Tørring,Bengt Hallengren,Peter Åsman

Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations

2016

Mikael Lantz
Jan Calissendorff
Frank Träisk
Leif Tallstedt
Tereza Planck
Ove Tørring
Bengt Hallengren
Peter Åsman

Background: Orbital morphological changes are often present in patients with Graves' disease (GD) already at diagnosis, and cyclooxygenase type 2 (COX-2) is overe

Keywords:

Graves' disease
Diclofenac
Disease
Anti-thyroid autoantibodies
Adjuvant
Antibody
Endocrinology
Cyclooxygenase
Internal medicine
Medicine
Diabetes mellitus
Gastroenterology
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations